The observed hypermethylated profiles of MBP within NAWM and MS lesions represent interesting independent observations, yet they could potentially be explained by differences in cellular composition between patients and controls and between lesions and NAWM, respectively [23]. The gene discussed is MBP; the disease is myeloid sarcoma.